Study reveals chromosome-level changes that relate to drug resistance in melanoma
Precision therapies targeting melanoma and other cancers have improved patient survival, but tumors often stop responding to drugs, and recent studies point to changes in DNA – both inside and outside chromosomes – as a driving factor in tumor genesis as well as in treatment resistance.
Source: news-medical.net